Go to Contents Go to Navigation

SK Biopharmaceuticals remains in red in Q3

All News 09:35 November 12, 2020

SEOUL, Nov. 12 (Yonhap) -- SK Biopharmaceuticals Co. on Thursday reported its third-quarter net loss of 63.1 billion won (US$56.7 million), remaining in the red compared with a year ago.

The company said in a regulatory filing that it continued to post an operating loss of 63 billion won for the July-September period, compared with a loss of 50.5 billion won a year earlier. Sales rose 4684.1 percent to 3.9 billion won.

Send Feedback
How can we improve?
Thanks for your feedback!